Jorge Monge Urrea MD

PubMed

• Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.
  Gaurav Varma, Lindsay Fogel, Beth Gordon, Mateo Mejia Saldarriaga, Jaeil Ahn
  Leukemia & Lymphoma. 2025-01-05
• 1 citations
  Exploring health disparities in diagnosing multiple myeloma.
  Nima Ghalehsari, Sofia Zahid, Olivia Main, Soeb Usta, John Patresan
  Expert Review of Hematology. 2024-10-01
• 5 citations
  Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma.
  Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez
  Blood Advances. 2024-08-13

Journal Articles

• Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition  
  Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Leukemia, 1/1/2014
• Sudden cardiac arrest at the finish line: in coronary ectopia, the cause of ischemia is from intramural course, not ostial location  
  Joggerst S, Monge J, Uribe C, Sherron S, Angelini P, Tex Heart Inst J, 1/1/2014
• Staging and prognostication of multiple myeloma  
  Fonseca R, Monge J, Dimopoulos MA, Expert Rev Hematol, 1/1/2014
• Myeloma: classification and risk assessment  
  Fonseca R, Monge J, Semin Oncol, 1/1/2013
• Biventricular takotsubo cardiomyopathy: case report and general discussion  
  Angelini P, Monge J, Simpson L, Tex Heart Inst J, 1/1/2013
• Newer concepts regarding adults with coronary artery aneurysms: are they all Kawasaki? Does it make a difference?  
  Angelini P, Monge J, Circulation, 1/1/2012
• Apical hypertrophic cardiomyopathy: preliminary attempt at palliation with use of subselective alcohol ablation  
  Angelini P, Uribe C, Monge J, Escobar JM, Hernandez-Vila E, Tex Heart Inst J, 1/1/2012
• Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in -17p high risk disease  
  Kortum KM, Langer C, Monge J, Bruins L, Egan JB, Zhu YX, Shi CX, Jedlowski P, Schmidt J, Ojha J, Bullinger L, Liebisch P, Kull M, Champion MD, Van Wier S, Ahmann G, Ra..., Br J Haematol, 1/10/2014
• Join now to see all

Books/Book Chapters

• Grossman & Baim's Cardiac Catheterization, Angiography, and Intervention 
  Chapter: Coronary Artery Anomalies 
  Angelini P, Monge JEditors: Moscucci M.Lippincott Williams & Wilkins, Philadelphia2014

Abstracts/Posters

• Harnessing the Epichaperome As a Therapeutic Approach in Multiple Myeloma
  Jorge Monge, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Cyclophosphamide, bortezomib, and dexamethasone (CYBORD) treatment for relapsed/refractory multiple myeloma
  Monge J, Kortum KM, Stewart AK, Bergsagel PL, Mikhael J, Reeder CB, Mayo A, Fonseca R, J Clin Oncol, 1/1/2014
• Calcium Isotopic Composition and Its Association With Multiple Myeloma Disease Activity
  Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, Blood, 1/1/2013
• Correlations Between Stenosis and Symptoms in Patients with an Anomalous Right Coronary Artery with Intramural Course
  Angelini P, Monge J, Uribe C, Willerson JT, Catheter Cardiovasc Interv, 1/1/2013
• Anomalous Right Coronary Artery from the Left Sinus of Valsalva: Pathophysiological Mechanisms Studied by Intravascular Ultrasound, Clinical Presentations and Response...
  Angelini P, Monge J, Forstall P, Ramirez JM, Uribe C, Hernandez E, J Am Coll Cardiol, 1/1/2013
• Evaluation of parental perception of their children’s weight in an elementary school in Mexico City
  Monge J, 16th International Meeting of the Training of the Students in Health Sciences in Catholic Universities, International Federation of Catholic Universities & the International Association of Catholic Medical Schools, Mexico, 1/1/2011
• Libman-Sacks Endocarditis: A Complication of Systemic Lupus Erythematosus
  Monge J, III International Health Sciences Congress, Anahuac University, Mexico City, Mexico, 1/1/2008
• Pathophysiology of Migraine: Fundamentals of Prevention
  Monge J, II International Health Sciences Congress, Anahuac University, Mexico City, Mexico, 1/1/2006
• Cyclophosphamide, bortezomib, and dexamethasone (CYBORD) treatment for relapsed/refractory multiple myeloma
  Monge J, Kortum KM, Stewart AK, Bergsagel PL, Mikhael J, Reeder CB, Mayo A, Fonseca R, ASCO, Chicago, IL, 1/2./2014
• Calcium Isotopic Composition and Its Association With Multiple Myeloma Disease Activity
  Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R, ASH, New Orleans, LA, 1/8./2013
• Development of a 47 Gene Sequencing Panel for Common Mutations Present in Multiple Myeloma: Results in 77 p53 Deleted Patients
  Kortuem KM, Langer C, Braggio E, Van Wier S, Monge J, Egan J, Bruins L, Schmidt J, Bullinger L, Kull M, Knop S, Einsele H, Stewart AK, ASH, New Orleans, LA, 1/10/2013
• Correlations Between Stenosis and Symptoms in Patients with an Anomalous Right Coronary Artery with Intramural Course
  Angelini P, Monge J, Uribe C, Willerson JT, SCAI, Orlando, FL, 1/10/2013
• Anomalous Right Coronary Artery From the Left Sinus of Valsalva: Pathophysiological Mechanisms Studied by Intravascular Ultrasound, Clinical Presentations and Response...
  Angelini P, Monge J, Forstall P, Ramirez JM, Uribe C, Hernandez E, TCT@ACC-i2: Invasive And Interventional Cardiology, ACC, San Francisco, CA, 1/11/2013
• Apical Hypertrophic Cardiomyopathy: A Preliminary Attempt at Palliation Using Subselective Alcohol Ablation
  Angelini P, Monge J, Uribe C, Escobar J, Hernandez E, TCT, Miami, FL, 1/25/2012
• Spontaneous Thrombosis of a Coronary Artery Fistula
  Monge J, EVS 2011, International Society of Endovascular Specialists, San Juan, Puerto Rico, 1/10/2011
• Join now to see all